Exploring the disease-modifying potential of calcium channel blockers in Parkinson's disease: Using population-based administrative data to inform clinical trials.
Exploring the disease-modifying potential of calcium channel blockers in Parkinson's disease: Using population-based administrative data to inform clinical trials.
批准号:
172481
负责人:
Marras Connie
金额:
$21.86万
依托单位国家:
加拿大
项目类别:
Salary Programs
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-09-01 至 2013-09-01
中文摘要
实验室模型有证据表明,一类常用于治疗高血压的药物(二氢吡啶类钙通道阻滞剂,DHP CCB)可能对帕金森病的进展具有保护作用。 该项目将探索
英文摘要
There is evidence from laboratory models that a class of medication commonly used to treat high blood pressure (dihydropyridine calcium channel blockers, DHP CCBs) may be protective against the progression of Parkinson's disease. This project will explor
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-steroidal anti-inflammatory drugs and Parkinson's disease progression
-
批准号:388664
-
项目类别:Operating Grants
-
资助金额:$5.46万
-
财政年份:2018
-
负责人:Marras Connie
-
依托单位:
Predicting outcome in Parkinson's disease cognitive impairment
-
批准号:267248
-
项目类别:Operating Grants
-
资助金额:$42.56万
-
财政年份:2012
-
负责人:Marras Connie
-
依托单位:
Exploring the disease-modifying potential of calcium channel blockers in Parkinson's disease: Using population-based administrative data to inform clinical trials.
-
批准号:172407
-
项目类别:Operating Grants
-
资助金额:$4.77万
-
财政年份:2008
-
负责人:Marras Connie
-
依托单位: